Health ❯Medicine

Pharmaceuticals

Weight Loss Weight Loss Drugs Drug Development Diabetes Clinical Trials Drug Safety Drug Approval Side Effects Antibiotics GLP-1 Drugs

4 ARTICLES

last wk.

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

The CHMP’s positive opinion sets the stage for final EU Commission approval to replace high-global-warming-potential propellant with Honeywell’s lower-carbon alternative throughout AstraZeneca’s regional supply

13 ARTICLES

last wk.

Global Regulators Halt Elevidys Gene Therapy Over Safety Concerns

5 ARTICLES

last wk.

EMA Recommends Restricted Approval for Eli Lilly’s Alzheimer’s Drug Kisunla

3 ARTICLES

last wk.

Non-Hormonal Male Pill YCT-529 Is Safe at Contraceptive Doses, Early Trial Finds

6 ARTICLES

last wk.

YCT-529 Pill Proves Safe in Phase 1 Trial, Set for Efficacy Testing

10 ARTICLES

last wk.

Cancer Drugs Reverse Alzheimer’s Pathology in Mice, Advance to Clinical Trials

9 ARTICLES

last mo.

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

4 ARTICLES

last mo.

New Oral β2 Agonist Preserves Muscle in Early Weight-Loss Trials

4 ARTICLES

last mo.

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

10 ARTICLES

last mo.

Medtech Products Recalls Children's Honey Cough Syrup Over Bacterial Contamination

3 ARTICLES

last mo.

Roche’s New Antibiotic Against Acinetobacter baumannii Advances to Phase III Trials

5 ARTICLES

2mo ago

Three Arrested After Unlicensed Weight-Loss Jab Leaves Woman Hospitalized

Particle.news

Pharmaceuticals

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

Global Regulators Halt Elevidys Gene Therapy Over Safety Concerns

EMA Recommends Restricted Approval for Eli Lilly’s Alzheimer’s Drug Kisunla

Non-Hormonal Male Pill YCT-529 Is Safe at Contraceptive Doses, Early Trial Finds

YCT-529 Pill Proves Safe in Phase 1 Trial, Set for Efficacy Testing

Cancer Drugs Reverse Alzheimer’s Pathology in Mice, Advance to Clinical Trials

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

New Oral β2 Agonist Preserves Muscle in Early Weight-Loss Trials

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

Medtech Products Recalls Children's Honey Cough Syrup Over Bacterial Contamination

Never miss stories about

Pharmaceuticals

Artificial Enzymes Designed by Computers Rival Natural Catalysts

Germany Faces Surge in Forged Prescriptions for Weight Loss Injections

Democratic-Led States Petition FDA to Remove Mifepristone Restrictions

US Penicillin Imports Shored Up British Medical Treatment on D-Day

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial

FDA Commissioner Pledges Safety Review of Abortion Pill Mifepristone

Biocon Secures CDSCO Approval for Generic Liraglutide

Étienne-Émile Baulieu, Inventor of RU-486, Dies at 98

Roche’s New Antibiotic Against Acinetobacter baumannii Advances to Phase III Trials

Three Arrested After Unlicensed Weight-Loss Jab Leaves Woman Hospitalized

Never miss stories about

Pharmaceuticals